Plasmodium

Plasmodium
source
Name	Plasmodium
Domain	Eukaryota
Kingdom	Chromista
Phylum	Apicomplexa
Class	Aconoidasida
Order	Haemospororida
Family	Plasmodiidae
Genus	Plasmodium
Type species	Plasmodium malariae
Subdivision ranks	Subgenera
Subdivision	Laverania, Plasmodium, Vinckeia

Plasmodium. It is a genus of unicellular parasitic eukaryotes belonging to the phylum Apicomplexa. These organisms are best known as the causative agents of malaria, a life-threatening disease transmitted through the bite of infected female Anopheles mosquitoes. The genus was first described in 1885 by the Italian physician Ettore Marchiafava and the Italian zoologist Angelo Celli, with the type species identified as Plasmodium malariae.

Taxonomy and classification

The taxonomic placement of the genus is within the order Haemospororida and the family Plasmodiidae. Historically, classification relied heavily on morphological characteristics observed in Giemsa-stained blood films, but modern methods incorporate molecular phylogenetics and genomic sequencing. Major subgenera include ''Laverania'', which contains the most virulent human species like P. falciparum, and ''Plasmodium'', which includes species such as P. vivax. Other subgenera, like ''Vinckeia'', primarily infect non-human mammals such as rodents. The World Health Organization and research bodies like the Centers for Disease Control and Prevention monitor taxonomic updates due to their implications for public health strategies.

Life cycle and morphology

The complex life cycle involves two hosts: a definitive insect host, typically a female Anopheles mosquito, and an intermediate vertebrate host, such as a human. In the mosquito, sexual reproduction occurs, leading to the formation of sporozoites that migrate to the salivary glands. Upon biting a human, these sporozoites enter the bloodstream and travel to the liver, invading hepatocytes to undergo asexual replication, a stage known as exoerythrocytic schizogony. The resulting merozoites then infect red blood cells, initiating the cyclical blood stage infection. Morphologically, species can be distinguished by stages like the characteristic ring form in blood smears, the mature trophozoite, and the segmented schizont.

Pathogenesis and disease

Infection leads to malaria, with clinical manifestations including cyclical fevers, chills, anemia, and splenomegaly. The most severe pathology is often associated with P. falciparum, which can cause cerebral malaria, acute respiratory distress syndrome, and multi-organ failure. Pathogenic mechanisms include cytoadherence of infected erythrocytes to vascular endothelium, rosetting, and massive hemolysis. Other species, like P. vivax and P. ovale, can form dormant hypnozoites in the liver, leading to relapses. The immune response is complex, involving both innate immunity and adaptive immunity.

Diagnosis and treatment

Definitive diagnosis traditionally relies on microscopic examination of blood films, but rapid diagnostic tests detecting specific antigens like histidine-rich protein 2 are widely used in endemic areas. Molecular techniques such as polymerase chain reaction offer high sensitivity for species identification. First-line treatment for uncomplicated malaria often involves artemisinin-based combination therapies, as recommended by the World Health Organization. For severe cases, intravenous artesunate is preferred. Treatment of relapsing forms requires additional drugs like primaquine to target liver-stage hypnozoites. Drug resistance, particularly to chloroquine and sulfadoxine/pyrimethamine, remains a major challenge.

Epidemiology and prevention

Malaria transmission is endemic in tropical and subtropical regions, primarily in Sub-Saharan Africa, Southeast Asia, and parts of South America. The World Health Organization estimates hundreds of millions of cases annually, with the highest burden in countries like Nigeria, the Democratic Republic of the Congo, and Mozambique. Prevention strategies include the use of insecticide-treated bed nets, indoor residual spraying, and chemoprophylaxis for travelers. The RTS,S/AS01 vaccine, developed by GlaxoSmithKline and the PATH Malaria Vaccine Initiative, represents a significant advancement. International efforts are coordinated by entities like the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Research and history

Scientific understanding advanced significantly with the work of Alphonse Laveran, who first observed the parasites in 1880, and Ronald Ross, who demonstrated the mosquito transmission in 1897. The Nobel Prize in Physiology or Medicine has been awarded for related discoveries, including to Ronald Ross in 1902 and Julius Wagner-Jauregg in 1927. Modern research focuses on vaccine development, novel antimalarial drugs, genetic modification of mosquitoes, and genomic studies of parasite populations. Institutions like the National Institutes of Health, the Wellcome Trust, and the Bill & Melinda Gates Foundation are major funders of this ongoing work.

Category:Apicomplexa Category:Parasites Category:Malaria